VMP 20594611000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets
BNF code 050301000BBABA0
Virtual Therapeutic Moiety Emtricitabine + Rilpivirine + Tenofovir disoproxil
Abbreviated name Emtr 200mg/Rilpivirine 25mg/Tenofovir disoproxil 245mg tab
Basis of preferred name Other
Date of name applicability 2 Apr 2025
Previous name Generic Eviplera 200mg/25mg/245mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Tenofovir disoproxil
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 245.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Emtricitabine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Rilpivirine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 703123005
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd)
Virtual Medicinal Product Packs
Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.

Feedback